to study search History No further version available for comparison

Follow-up of patients from the study "Analysis of hemolysis frequency and dynamics in coronary bypass operations with and without Heart-lung machine"

Organizational Data

DRKS-ID:
DRKS00025843
Recruitment Status:
Recruiting planned
Date of registration in DRKS:
2021-07-14
Last update in DRKS:
2021-07-14
Registration type:
Prospective

Acronym/abbreviation of the study

Hemolysis study

URL of the study

No Entry

Brief summary in lay language

In cardiac surgery, blood can be observed in the urine in a non-specific and occasionally perioperative manner. This blood in the urine is the result of destruction of blood cells. This can be a side effect when using the heart-lung machine. Possible triggers are e.g. mechanical damage caused by roller pumps, shear stress of the blood cells. A comparative study at the Surgical Clinic Munich South (Ethics Proposal No: 18-633 of 29.10.2018) answered the question of whether laboratory chemical values are measurable with regard to blood in the urine, in cardiac surgery generally increased or whether it is explicitly a side effect of the heart-lung machine. Laboratory values of patients with elective coronary bypass operations with and without a heart-lung machine were compared.The results of the study show significant differences in laboratory values to the detriment of the group of patients who were operated on with the heart-lung machine. A dysfunction of the kidney is a dreaded long-term complication. In order to be able to assess potential kidney damage with regard to the heart surgery patient clientele of the study, patients will be interviewed in this follow-up study.

Brief summary in scientific language

In cardiac surgery, macrohematuria can be observed non-specifically and occasionally perioperatively. Macrohematuria is the result of intravascular hemolysis as a side effect of the heart-lung machine. Possible triggers of hemolysis are mechanical damage caused by roller pumps, shear stress of the blood cells or the reduced oncotic pressure due to the dilution of the plasma. A monocentric, prospective comparative analysis at the Surgical Clinic Munich South (Ethics Proposal No: 18-633 of 29.10.2018) answered the question of whether laboratory chemical hemolysis parameters can be measured in cardiac surgery in general or whether it is explicitly a side effect of extracorporeal circulation. Hemolysis parameters of patients with elective coronary bypass surgery with and without a heart-lung machine were compared. The results of the hemolysis study show significant differences in laboratory chemical hemolysis parameters (free hemoglobin, haptoglobin and lactate dehydrogenase) to the detriment of the patient group operated with the heart-lung machine. Dysfunction of the renal tubules is a dreaded complication of intravascular hemolysis. In order to be able to assess potential nephrological consequential damage with regard to the cardiac surgical patient clientele of the hemolysis study, patients will be interviewed in this follow-up study.

Health condition or problem studied

ICD10:
D59.6 - Haemoglobinuria due to haemolysis from other external causes
Healthy volunteers:
No Entry

Interventions, Observational Groups

Arm 1:
In >20 patients (Group A) were operated without heart lung machine.
Arm 2:
In >20 patients (Group B) the heart lung machine was used.

Endpoints

Primary outcome:
The primary goal of this "hemolysis study" is to check the kidney function of patients after coronary bypass surgery with and without heart-lung machine (HLM) on the basis of special postoperative laboratory parameters (especially haptoglobilin, free Hb, but also creatinine, urea, GFR). Central goal: Is kidney function less severely impaired after bypass surgery without HLM?
Secondary outcome:
Hb, leukocytes, hematocrit, platelets, K, Na, Quick, PTT, bilirubin, GOT, GPT, gamma-GT Questionnaire with assessment of quality of life (Visual analogical scale 1-10), recording of complications (morbidity, including further operations, cardiac catheterization procedures, pumping power of the heart), mortality

Study Design

Purpose:
Basic research/physiological study
Retrospective/prospective:
No Entry
Study type:
Non-interventional
Longitudinal/cross-sectional:
No Entry
Study type non-interventional:
No Entry

Recruitment

Recruitment Status:
Recruiting planned
Reason if recruiting stopped or withdrawn:
No Entry

Recruitment Locations

Recruitment countries:
  • Germany
Number of study centers:
Monocenter study
Recruitment location(s):
  • Medical center Artemed Klinikum München Süd München

Recruitment period and number of participants

Planned study start date:
2021-08-01
Actual study start date:
No Entry
Planned study completion date:
No Entry
Actual Study Completion Date:
No Entry
Target Sample Size:
40
Final Sample Size:
No Entry

Inclusion Criteria

Sex:
All
Minimum Age:
18 Years
Maximum Age:
no maximum age
Additional Inclusion Criteria:
Coronary bypass surgery, minimum age 18 years, positive patient consent

Exclusion Criteria

Emergency surgery, no consent, incapacitated, additional surgery (combination procedure), neurological deficit, dialysis preoperative, severe renal impairment

Addresses

Primary Sponsor

Address:
HerzchirurgieArtemed Klinikum München süd
Dr. Helmut Mair
Am Isarkanal 30
81379 München
Germany
Telephone:
+49 89 724400
Fax:
+49 89 72440355
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry
Investigator Sponsored/Initiated Trial (IST/IIT):
Yes

Contact for Scientific Queries

Address:
HerzchirurgieArtemed Klinikum München Süd
Dr. Helmut Mair
Am Isarkanal 30
81379 München
Germany
Telephone:
+49 89 724400
Fax:
+49 89 72440355
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Contact for Public Queries

Address:
HerzchirurgieArtemed Klinikum München Süd
Dr. Helmut Mair
Am Isarkanal 30
81379 München
Germany
Telephone:
+49 89 724400
Fax:
+49 89 72440355
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Principal Investigator

Address:
HerzchirurgieArtemed Klinikum München Süd
Dr. Helmut Mair
Am Isarkanal 30
81379 München
Germany
Telephone:
+49 89 724400
Fax:
+49 89 72440355
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Sources of Monetary or Material Support

Institutional budget, no external funding (budget of sponsor/PI)

Address:
HerzchirurgieArtemed Klinikum München Süd
Am Isarkanal 30
81379 München
Germany
Telephone:
+49 89 724400
Fax:
+49 89 72440355
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Ethics Committee

Address Ethics Committee

Address:
Ethikkommission der Med. Fakultät der LMU
Pettenkoferstraße 8
80336 München
Germany
Telephone:
+49-89-440055191
Fax:
+49-89-440055192
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Vote of leading Ethics Committee

Vote of leading Ethics Committee
Date of ethics committee application:
2020-02-17
Ethics committee number:
20-143
Vote of the Ethics Committee:
Approved
Date of the vote:
2021-02-02

Further identification numbers

Other primary registry ID:
No Entry
EudraCT Number:
No Entry
UTN (Universal Trial Number):
No Entry
EUDAMED Number:
No Entry

IPD - Individual Participant Data

Do you plan to make participant-related data (IPD) available to other researchers in an anonymized form?:
No
IPD Sharing Plan:
No Entry

Study protocol and other study documents

Study protocols:
No Entry
Study abstract:
No Entry
Other study documents:
No Entry
Background literature:
No Entry
Related DRKS studies:
No Entry

Publication of study results

Planned publication:
No Entry
Publikationen/Studienergebnisse:
No Entry
Date of first publication of study results:
No Entry
DRKS entry published for the first time with results:
No Entry

Basic reporting

Basic Reporting / Results tables:
No Entry
Brief summary of results:
No Entry